Skip to main content
James Ruggles, MD, Psychiatry, Stockton, CA

JamesARugglesMD

Psychiatry Stockton, CA

Child & Adolescent Psychiatry

Physician

Are you Dr. Ruggles?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 34 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1341 W Robinhood Dr Ste B6
    Stockton, CA 95207
    Phone+1 209-481-3446
    Fax+1 209-474-6468

Summary

  • Dr. James Ruggles, MD is a board certified psychiatrist in Stockton, California. He is currently licensed to practice medicine in California, Oregon, and Iowa. He is affiliated with Dameron Hospital.

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Child and Adolescent Psychiatry, 1980 - 1983
  • University of California Davis Health
    University of California Davis HealthResidency, Psychiatry, 1973 - 1975
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Psychiatry, 1972 - 1973
  • Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Hospital and Health CenterInternship, Transitional Year, 1971 - 1972
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2025
  • OR State Medical License
    OR State Medical License 1975 - 2019
  • IA State Medical License
    IA State Medical License 1972 - 2001
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child Psychiatry

Publications & Presentations

PubMed

Press Mentions

  • Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents Aged 10
    Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents Aged 10June 25th, 2021